default author photo

Kersten Borchert

University of Rostock - University Medicine Rostock (UMR)

Rostock

Germany

SCHOLARLY PAPERS

1

DOWNLOADS

30

TOTAL CITATIONS

2

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Cisplatin and 5-Fluorouracil with or Without Epidermal Growth Factor Receptor Inhibition Panitumumab for Patients with Non-Resectable, Advanced or Metastatic Esophageal Squamous Cell Cancer: A Prospective, Open-Label, Randomised Phase 3 AIO/EORTC Trial (Power)

Number of pages: 31 Posted: 17 Apr 2019
Markus Moehler, Annett Maderer, Peter C. Thuss-Patience, Baruch Brenner, Johannes Meiler, Thomas J. Ettrich, Ralf-Dieter Hofheinz, Salah-Eddin Al-Batran, Arndt Vogel, Lothar Mueller, Manfred P. Lutz, Florian Lordick, Maria Alsina, Kersten Borchert, Richard Greil, Wolfgang Eisterer, Arno Schad, Julia Slotta-Huspenina, Eric Van Cutsem and Sylvie Lorenzen
Johannes Gutenberg University Mainz - I. Med. Klinik und Poliklinik, Johannes Gutenberg University Mainz - I. Med. Klinik und Poliklinik, Charité - Universitätsmedizin Berlin, Tel Aviv University - Sackler Faculty of Medicine, University of Duisburg-Essen - University Hospital Essen, University Hospital Ulm, University of Mannheim, Krankenhaus Nordwest General Hospital - Institute of Clinical Cancer Research (ICCR), Hannover Medical School - Department of Gastroenterology, Hepatology and Endocrinology, Onkologie Leer-Emden-Papenburg, Caritas Klinikum, University of Leipzig - Faculty of Medicine, Autonomous University of Barcelona - Institute of Oncology (VHIO), University of Rostock - University Medicine Rostock (UMR), Paracelsus Medical University Salzburg, Medical University of Innsbruck, Johannes Gutenberg University Mainz, Technische Universität München (TUM) - Institute of Pathology, KU Leuven and Technische Universität München (TUM)
Downloads 30 (1,318,317)
Citation 2

Abstract:

Loading...

esophageal squamous cell cancer, panitumumab, EGFR, palliative chemotherapy, cisplatin, 5-fluorouracil